← Browse by Condition
Medical Condition
ccne1 amplification
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2, Phase 1
NCT05867251 Phase 1, Phase 2
Recruiting
Study of AVZO-021 in Patients With Advanced Solid Tumors
Enrollment
430 pts
Location
United States, Austr...
Sponsor
Avenzo Therapeutics, Inc.
NCT06586957 Phase 1
Recruiting
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Enrollment
150 pts
Location
United States
Sponsor
NiKang Therapeutics, Inc.